Healthcare Ventures Vii Lp - Net Worth and Insider Trading

Healthcare Ventures Vii Lp Net Worth

The estimated net worth of Healthcare Ventures Vii Lp is at least $111 dollars as of 2024-05-21. Healthcare Ventures Vii Lp is the of GlobeImmune Inc and owns about 554,267 shares of GlobeImmune Inc (GBIM) stock worth over $111. Details can be seen in Healthcare Ventures Vii Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Healthcare Ventures Vii Lp has not made any transactions after 2016-02-19 and currently still holds the listed stock(s).

Transaction Summary of Healthcare Ventures Vii Lp

Healthcare Ventures Vii Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Healthcare Ventures Vii Lp owns 4 companies in total, including GlobeImmune Inc (GBIM) , TetraLogic Pharmaceuticals Corp (TLOG) , and Radius Health Inc (RDUS) among others .

Click here to see the complete history of Healthcare Ventures Vii Lp’s form 4 insider trades.

Insider Ownership Summary of Healthcare Ventures Vii Lp

Ticker	Comapny	Transaction Date	Type of Owner
GBIM	GlobeImmune Inc	2016-02-19	other: Former 10% Owner
TLOG	TetraLogic Pharmaceuticals Corp	2013-12-17	10 percent owner
RDUS	Radius Health Inc	2011-05-17	10 percent owner
		2009-07-28	10 percent owner

Healthcare Ventures Vii Lp Latest Holdings Summary

Healthcare Ventures Vii Lp currently owns a total of 1 stock. Healthcare Ventures Vii Lp owns 554,267 shares of GlobeImmune Inc (GBIM) as of February 19, 2016, with a value of $111.

Latest Holdings of Healthcare Ventures Vii Lp

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
GBIM	GlobeImmune Inc	2016-02-19	554,267	0.00	111

Holding Weightings of Healthcare Ventures Vii Lp

Healthcare Ventures Vii Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Healthcare Ventures Vii Lp has made a total of 0 transactions in GlobeImmune Inc (GBIM) over the past 5 years. The most-recent trade in GlobeImmune Inc is the sale of 15,000 shares on February 19, 2016, which brought Healthcare Ventures Vii Lp around $21,600.

Insider Trading History of Healthcare Ventures Vii Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Healthcare Ventures Vii Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Healthcare Ventures Vii Lp Ownership Network

Ownership Network List of Healthcare Ventures Vii Lp

No Data

Ownership Network Relation of Healthcare Ventures Vii Lp

Healthcare Ventures Vii Lp Owned Company Details

What does GlobeImmune Inc do?

Who are the key executives at GlobeImmune Inc?

Healthcare Ventures Vii Lp is the other: Former 10% Owner of GlobeImmune Inc. Other key executives at GlobeImmune Inc include other: Former 10% Owner John W Littlechild , other: Former 10% Owner James H Cavanaugh , and other: Former 10% Owner Harold R Werner .

GlobeImmune Inc (GBIM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GlobeImmune Inc (GBIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GlobeImmune Inc (GBIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GlobeImmune Inc (GBIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlobeImmune Inc Insider Transactions

No Available Data

What does TetraLogic Pharmaceuticals Corp do?

Who are the key executives at TetraLogic Pharmaceuticals Corp?

Healthcare Ventures Vii Lp is the 10 percent owner of TetraLogic Pharmaceuticals Corp. Other key executives at TetraLogic Pharmaceuticals Corp include other: See Remarks Hudson Bay Capital Management Lp , other: See Remarks Lazard Asset Management Llc , and other: See Remarks Nomura Holdings Inc .

TetraLogic Pharmaceuticals Corp (TLOG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TetraLogic Pharmaceuticals Corp (TLOG)'s detailed insider trading history can be found in Insider Trading Tracker table.

TetraLogic Pharmaceuticals Corp Insider Transactions

No Available Data

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Healthcare Ventures Vii Lp is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Healthcare Ventures Vii Lp is the 10 percent owner of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Healthcare Ventures Vii Lp made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Richard I Eisenstadt .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

Healthcare Ventures Vii Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Healthcare Ventures Vii Lp. You might contact Healthcare Ventures Vii Lp via mailing address: 55 Cambridge Parkway, Suite 301, Cambridge Ma 02142.

Discussions on Healthcare Ventures Vii Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.